Cost-Effectiveness of Sacubitril-Valsartan in Patients Who Have Heart Failure With Reduced Ejection Fraction

Ann Intern Med. 2017 Apr 18;166(8):607-608. doi: 10.7326/L17-0044.

Authors

Alexander T Sandhu¹, Daniel A Ollendorf¹, Richard H Chapman¹, Steven D Pearson¹, Paul A Heidenreich¹

Affiliation

¹ From Stanford University, Stanford, California; Institute for Clinical and Economic Review, Boston, Massachusetts; Veterans Affairs Palo Alto Health Care System, Palo Alto, California.

PMID: 28418550
DOI: 10.7326/L17-0044

No abstract available

Publication types

Comment

MeSH terms

Aminobutyrates
Biphenyl Compounds
Cost-Benefit Analysis*
Drug Combinations
Heart Failure
Humans
Stroke Volume*
Tetrazoles
Valsartan

Substances

Aminobutyrates
Biphenyl Compounds
Drug Combinations
Tetrazoles
Valsartan
sacubitril and valsartan sodium hydrate drug combination